Page last updated: 2024-10-30

linopirdine and Hypertension, Pulmonary

linopirdine has been researched along with Hypertension, Pulmonary in 1 studies

linopirdine: acetylcholine releasing drug

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research Excerpts

ExcerptRelevanceReference
" Moreover, oral dosing with flupirtine (30 mg/kg/day) prevented short-term in vivo hypoxia from increasing pulmonary vascular resistance and sensitizing the arteries to acute hypoxia."1.42Role of Kv7 channels in responses of the pulmonary circulation to hypoxia. ( Brennan, S; Ghaly, Y; Gurney, AM; Herget, J; Joshi, S; Mizera, R; Novotna, J; Sedivy, V; Zaloudikova, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sedivy, V1
Joshi, S1
Ghaly, Y1
Mizera, R1
Zaloudikova, M1
Brennan, S1
Novotna, J1
Herget, J1
Gurney, AM1

Other Studies

1 other study available for linopirdine and Hypertension, Pulmonary

ArticleYear
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Jan-01, Volume: 308, Issue:1

    Topics: Aminopyridines; Analgesics; Animals; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; I

2015